Revised February 2018
Opioid-Related Overdose Deaths
In 2016, there were 865 opioid-related overdose deaths in Wisconsin—a rate of 15.8 deaths per 100,000 persons—compared to the national rate of 13.3 deaths per 100,000. Since 2010, heroin overdose deaths have increased from 92 to 389 deaths—a more than fourfold increase. Deaths attributed to synthetic opioids (mainly fentanyl) increased similarly from 66 to 288 deaths and deaths due to prescription opioids increased from 285 to 382 deaths.
Opioid Pain Reliever Prescriptions
In 2015, Wisconsin providers wrote 69.1 opioid prescriptions per 100 persons (4 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
The incidence of NAS in Wisconsin increased from 0.4 cases per 1,000 births in 1999 to 7.9 cases per 1,000 in 2013—a nearly twentyfold increase. The average across the 28 states included in the 2013 analysis was 6.0 cases per 1,000 births (CDC, MMWR, 2014).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 229 occurred in Wisconsin, with 4.1 percent1 of males and 17.1 percent of females had new HIV cases attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 5,952 persons were living with a diagnosed HIV in Wisconsin—a rate of 123 cases per 100,000 persons. Of these, 15.8 percent1 of males and 21.3 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Wisconsin reported 3,745 total cases of HCV, including 61 acute cases, at rates of 65.3 cases per 100,000 persons and 1.1 cases per 100,000 persons, respectively. Of the acute cases, 67 percent were attributed to IDU (Wisconsin.gov).
- State Prevalence: As of 2015, an estimated 90,000 persons were living with HCV in Wisconsin (Wisconsin.gov).
- Wisconsin Department of Health Services, Opioids
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Wisconsin, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH HEAL (Helping to End Addiction Long-term) Initiative
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number.